Saturday, October 8, 2022
11:00 AM – 12:15 PM Eastern, 5:00 PM – 6:15 PM Central European
Virtual Symposium live at: 11:00 AM Eastern; 10:00 AM Central; 9:00 AM Mountain; 8:00 AM Pacific
Program Features
- Interactive, Case-Based Challenge
- Complimentary Personalized Online Poster Portal
- Whiteboard Animation
Faculty
Guillermo E. Umpierrez, MD, CDCES, FACE, MACP
Professor of Medicine
Emory University
President for Medicine and Science
American Diabetes Association
Atlanta, GA
Prof. Dr. med. Dr. h. c. Michael A. Nauck
St.Josef- Hospital Bochum (GER)
Ruhr- University-Bochum
Head of Clinical Research (Section Diabetology)
Bochum, Germany
PROGRAM DESCRIPTION
This activity features education regarding the links between obesity and diabetes, the role of the incretin system in these metabolic disorders, and use of incretin therapies to manage diabetes-related obesity.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Determine which patients with T2DM are poised to benefit from earlier treatment intensification to achieve optimal glycemic and metabolic outcomes
- Assess the safety, efficacy, and mechanisms of GIP/GLP-1 receptor agonists
- Explain the potential role of GIP/GLP-1 receptor agonists in the treatment of patients with T2DM
- Implement a shared decision making approach to help patients with T2DM achieve and maintain weight loss for more optimal outcomes
TARGET AUDIENCE
This educational activity is intended for endocrinologists who treat patients with T2DM globally.
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live virtual activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live virtual activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with diabetes-related obesity. Credits: 1.25 ANCC Contact Hours.
CNE Accreditation Statement: Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.25 contact hours of continuing nursing education of RNs and APNs.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITY ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
